Literature DB >> 12566858

Establishment of the mouse as a model animal for the study of diabetic cataracts.

K R Hegde1, M G Henein, S D Varma.   

Abstract

The purpose of the present study was to investigate the suitability of using the mouse, a species known to have a low lens aldose reductase activity, as a model animal for studying the pathogenesis of diabetic cataract. Earlier studies with diabetic rats whose cataract development is much faster can only partially explain the etiology of cataracts in humans where lens aldose reductase is substantially low. CD-1 mice were injected intraperitoneally with streptozotocin according to Rossini's method. Blood glucose levels were estimated after 7 days, and animals having blood glucose between 300 and 400 mg/dl were selected for further experiments. Development of lenticular opacity was followed by examining the animals every 3-4 weeks by direct ophthalmoscopy, slitlamp examination and Scheimpflug photography. Additionally, the animals were sacrificed at appropriate intervals, eyes enucleated and subjected to morphological studies. The presence of refractive changes and early cataract in the diabetic mice was initially ascertained by the distorted appearance of the grid pattern when seen through the isolated lenses. Early cataracts were visible on slitlamp examination and by ophthalmoscopy as early as 3-4 weeks after the establishment of diabetes. Advanced opacity was clearly documentable by photography after 5-6 months. Similar to that in other species, a single layer of anterior epithelial cells abutting the anterior capsule was seen in the histological sections of normal mouse lenses. On the contrary, the epithelium in the diabetic lens was multilayered, and numerous nucleated cells were visible in the superficial anterior cortex. These studies therefore suggest that further studies with mice may throw additional light on the contribution of diabetes in the pathogenesis of cataracts in low lens aldose reductase models. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566858     DOI: 10.1159/000068193

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  8 in total

1.  Prevention of cataract by pyruvate in experimentally diabetic mice.

Authors:  K R Hegde; S D Varma
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Morphogenetic and apoptotic changes in diabetic cataract: prevention by pyruvate.

Authors:  K R Hegde; S D Varma
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

3.  In vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility.

Authors:  Maria I Avrutsky; Carol M Troy; Claire W Chen; Anna M Potenski; Crystal K Colón Ortiz
Journal:  J Vis Exp       Date:  2022-04-21       Impact factor: 1.424

4.  Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice.

Authors:  Emrah Kan; Elif Kiliçkan; Ahmet Ayar; Ramis Çolak
Journal:  Int Ophthalmol       Date:  2014-12-09       Impact factor: 2.031

5.  Effect of thioltransferase on oxidative stress induced by high glucose and advanced glycation end products in human lens epithelial cells.

Authors:  Qing Liu; Xu Wang; Hong Yan
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

6.  Electron impact mass spectroscopic studies on mouse retinal fatty acids: effect of diabetes.

Authors:  K R Hegde; S D Varma
Journal:  Ophthalmic Res       Date:  2009-05-28       Impact factor: 2.892

7.  Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.

Authors:  Chieh Allen Lee; Guangyuan Li; Mansi D Patel; J Mark Petrash; Beth Ann Benetz; Alex Veenstra; Jaume Amengual; Johannes von Lintig; Christopher J Burant; Johnny Tang; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

8.  Aquaporin 5 knockout mouse lens develops hyperglycemic cataract.

Authors:  S Sindhu Kumari; Kulandaiappan Varadaraj
Journal:  Biochem Biophys Res Commun       Date:  2013-10-19       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.